Published by Josh White on 15th June 2022
(Sharecast News) - Immunotherapy developer Scancell updated the market on the phase 2 'SCOPE' clinical trial in melanoma patients on Wednesday, being conducted at multiple centres in the UK.
URL: http://www.digitallook.com/dl/news/story/32751991/...